Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Risperidone-induced enuresis in two children with autistic disorder.

Hergüner S, Mukaddes NM.

J Child Adolesc Psychopharmacol. 2007 Aug;17(4):527-30.

PMID:
17822346
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.

Harrison-Woolrych M, Skegg K, Ashton J, Herbison P, Skegg DC.

Br J Psychiatry. 2011 Aug;199(2):140-4. doi: 10.1192/bjp.bp.110.087478. Epub 2011 Jun 8.

4.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

5.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
6.

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Hellings JA, Zarcone JR, Crandall K, Wallace D, Schroeder SR.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):229-38.

PMID:
11642473
7.

Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation.

Kumazaki H, Watanabe K, Imasaka Y, Iwata K, Tomoda A, Mimura M.

J Clin Psychopharmacol. 2014 Oct;34(5):624-6. doi: 10.1097/JCP.0000000000000197.

PMID:
25118082
8.

Imipramine for enuresis associated with risperidone.

Hergüner S, Hergüner A, Küçükapan HU.

J Clin Psychopharmacol. 2011 Dec;31(6):782-3. doi: 10.1097/JCP.0b013e318235c330. No abstract available.

PMID:
22051922
9.

Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine.

Mergui J, Jaworowski S.

Clin Neuropharmacol. 2016 May-Jun;39(3):152-3. doi: 10.1097/WNF.0000000000000142.

PMID:
26992158
10.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
11.

Risperidone in children with autism and serious behavioral problems.

McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D; Research Units on Pediatric Psychopharmacology Autism Network.

N Engl J Med. 2002 Aug 1;347(5):314-21.

12.

Enuresis with combined risperidone and SSRI use.

Took KJ, Buck BJ.

J Am Acad Child Adolesc Psychiatry. 1996 Jul;35(7):840-1. No abstract available.

PMID:
8768340
13.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
14.

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Findling RL, Maxwell K, Wiznitzer M.

Psychopharmacol Bull. 1997;33(1):155-9.

PMID:
9133768
15.

Desmopressin Use in the Treatment of Aripiprazole-Induced Nocturnal Enuresis in a Child Diagnosed with Autıstıc Disorder.

Karakurt MN, Süren S.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):518-9. doi: 10.1089/cap.2015.0003. Epub 2015 Jul 29. No abstract available.

PMID:
26222623
16.

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.

Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S.

Paediatr Drugs. 2013 Dec;15(6):505-14. doi: 10.1007/s40272-013-0036-2.

PMID:
23821414
17.

A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

Masi G, Cosenza A, Mucci M, Brovedani P.

J Clin Psychiatry. 2003 Sep;64(9):1039-47.

PMID:
14628979
18.

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.

Malone RP, Maislin G, Choudhury MS, Gifford C, Delaney MA.

J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2):140-7.

PMID:
11837403
19.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
20.

Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.

Zuddas A, Di Martino A, Muglia P, Cianchetti C.

J Child Adolesc Psychopharmacol. 2000 Summer;10(2):79-90.

PMID:
10933118

Supplemental Content

Support Center